Snorkel AI helps MSKCC streamline HER-2 patient identification
MSKCC needed to classify HER2 protein status in patient records to identify clinical-trial candidates, but manual review was slow since only physicians and researchers could label the complex unstructured data, creating bottlenecks in speed, consistency, and disagreement detection. Snorkel's team worked with MSKCC to build eight imperfect programmatic labeling functions that Snorkel combined to auto-label raw data, iteratively refined via model-guided error analysis that caught mislabeled ground truth, then trained an XGBoost model on the result. The final model reached 93% overall accuracy (92% on the test set) and an 87% average F1 score across classes, auto-labeling thousands of records in weeks instead of months; one engineer said a prior regex model took a long time to build, whereas with Snorkel "it was a few hours to get to the results we achieved."
Snorkel AI is a data-development and evaluation company whose programmatic labeling tools build training and benchmark datasets used to stress-test whether a model approach is viable before a full build.
This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.
Published by Snorkel AI on its own site — read the original case study on snorkel.ai ↗
Related use cases
- 01DIU Enhances Decision-Making Resilience with Snorkel AI
- 02Experian Improved Agent Response Times Under 3 Seconds with Snorkel
- 03How Rox achieved 99% accuracy with Snorkel
- 04Deploying production AI in <60 days to accelerate claims review 67%
- 05From hours to seconds on CLO contract review with 94% end user acceptance
- 06Global media intelligence company cuts analysis time to 15 seconds